These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3050008)

  • 1. Isolation and analysis of ketoconazole resistant mutants of Saccharomyces cerevisiae.
    Watson PF; Rose ME; Kelly SL
    J Med Vet Mycol; 1988 Jun; 26(3):153-62. PubMed ID: 3050008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic and physiological analysis of azole sensitivity in Saccharomyces cerevisiae.
    Kenna S; Bligh HF; Watson PF; Kelly SL
    J Med Vet Mycol; 1989; 27(6):397-406. PubMed ID: 2560793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of the Saccharomyces cerevisiae gene for NADPH-cytochrome P450 reductase causes increased sensitivity to ketoconazole.
    Sutter TR; Loper JC
    Biochem Biophys Res Commun; 1989 May; 160(3):1257-66. PubMed ID: 2543395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a cytochrome P450 deficient mutant of Candida albicans.
    Bard M; Lees ND; Barbuch RJ; Sanglard D
    Biochem Biophys Res Commun; 1987 Sep; 147(2):794-800. PubMed ID: 3307785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on azole-induced cell death in Saccharomyces cerevisiae.
    Kelly SL; Kenna S; Arnoldi A; Kelly DE
    FEMS Microbiol Lett; 1994 Jan; 115(2-3):219-22. PubMed ID: 8138136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ketoconazole on potassium pool, c-AMP-release and ergosterol synthesis in resistant mutants of Microsporum gypseum.
    Merkunová A; Lenhart K
    Acta Univ Palacki Olomuc Fac Med; 1994; 137():19-21. PubMed ID: 7778499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characteristics of the final stages of ergosterol biosynthesis in Saccharomyces cerevisiae yeasts].
    Zhakovskaia ZA; Mikhaĭlova NP; Kamilova TA; Ogorodnikova TE; V'iunov KA
    Izv Akad Nauk SSSR Biol; 1989; (1):95-101. PubMed ID: 2654239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective sterol C5-6 desaturation and azole resistance: a new hypothesis for the mode of action of azole antifungals.
    Watson PF; Rose ME; Ellis SW; England H; Kelly SL
    Biochem Biophys Res Commun; 1989 Nov; 164(3):1170-5. PubMed ID: 2556119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of nystatin-resistant mutants of Saccharomyces cerevisiae and preparation of sterol intermediates using the mutants.
    Nakanishi S; Nishino T; Nagai J; Katsuki H
    J Biochem; 1987 Feb; 101(2):535-44. PubMed ID: 3294819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ertosterol biosynthesis in Saccharomyces cerevisiae: mutants deficient in the early steps of the pathway.
    Karst F; Lacroute F
    Mol Gen Genet; 1977 Sep; 154(3):269-77. PubMed ID: 200835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiological effects of fenpropimorph on wild-type Saccharomyces cerevisiae and fenpropimorph-resistant mutants.
    Lorenz RT; Parks LW
    Antimicrob Agents Chemother; 1991 Aug; 35(8):1532-7. PubMed ID: 1929324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketoconazole-resistant mutants of Microsporum gypseum. I. Isolation of mutants, biochemical methods.
    Lenhart K; Merkunová A; Walterová D; Latinák J; Kozený M
    Acta Univ Palacki Olomuc Fac Med; 1989; 122():55-70. PubMed ID: 2530847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of a cytochrome P-450 structural gene from Saccharomyces cerevisiae.
    Kalb VF; Loper JC; Dey CR; Woods CW; Sutter TR
    Gene; 1986; 45(3):237-45. PubMed ID: 3542713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two species of cytochrome P-450 involved in ergosterol biosynthesis of yeast.
    Hata S; Nishino T; Katsuki H; Aoyama Y; Yoshida Y
    Biochem Biophys Res Commun; 1983 Oct; 116(1):162-6. PubMed ID: 6357195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yeast mutants requiring ergosterol as only lipid supplement.
    Gollub EG; Trocha P; Liu PK; Sprinson DB
    Biochem Biophys Res Commun; 1974 Jan; 56(2):471-7. PubMed ID: 4363054
    [No Abstract]   [Full Text] [Related]  

  • 16. NADPH cytochrome P-450 oxidoreductase and susceptibility to ketoconazole.
    Venkateswarlu K; Kelly DE; Manning NJ; Kelly SL
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1756-61. PubMed ID: 9661017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of oxygen deficiency on the stability of the yeast Saccharomyces cerevisiae to the polyenic antibiotic nystatin].
    Ekhvalova TV; Mikhaĭlova NP; Ogorodnikova TE; V'iunov KA
    Mikrobiologiia; 1989; 58(2):199-201. PubMed ID: 2682142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sterol biosynthesis in antibiotic-resistant yeast: nystatin.
    Fryberg M; Oehlschlager AC; Unrau AM
    Arch Biochem Biophys; 1974 Jan; 160(1):83-9. PubMed ID: 4597559
    [No Abstract]   [Full Text] [Related]  

  • 19. Modulation of fluconazole sensitivity by the interaction of mitochondria and erg3p in Saccharomyces cerevisiae.
    Kontoyiannis DP
    J Antimicrob Chemother; 2000 Aug; 46(2):191-7. PubMed ID: 10933640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of Saccharomyces cerevisiae mutants with a different degree of resistance to killer toxins K1 and K2.
    Flegelová H; Novotná D; Vojtísková K; Janderová B
    FEMS Yeast Res; 2002 Mar; 2(1):73-9. PubMed ID: 12702323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.